Literature DB >> 14622476

Free-beam and contact laser coagulation.

Rolf Muschter1.   

Abstract

Laser coagulation of benign prostatic hyperplasia (BPH) encompasses a variety of techniques using different laser wavelengths, application systems, and surgical techniques to achieve contrasting tissue effects. During transurethral laser coagulation, known as visual laser ablation of the prostate (VLAP), the prostate is irradiated by free-beam Nd:YAG or diode laser energy. The coagulated and necrotic tissue sloughs off within weeks to months. In randomized studies comparing laser coagulation and transurethral resection of the prostate (TURP), symptoms and some voiding parameters improved significantly after laser coagulation, although not to the level obtained with TURP. However, the operative duration and the length of hospitalization have been shorter than for TURP, and major complications have not occurred. Follow-up clinical data and retreatment rates are available for up to 5 years with a remarkable variability. Although retreatment rates may be high, patients who are "responders" to the treatment after 2 to 3 years seem to have durable results after 4 to 5 years and even longer.

Entities:  

Mesh:

Year:  2003        PMID: 14622476     DOI: 10.1089/089277903322518572

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  6 in total

1.  Prostate vaporization in the treatment of benign prostatic hyperplasia by using a 200-w high-intensity diode laser.

Authors:  Po-Hui Chiang; Chien-Hsu Chen
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

2.  [Holmium laser ablation of the prostate. An alternative to GreenLight photoselective vaporization of the prostate].

Authors:  M Richter; J Schwarz; P De Geeter; P Albers
Journal:  Urologe A       Date:  2009-03       Impact factor: 0.639

3.  [Thulium:YAG vaporesection of the prostate. First results].

Authors:  T Bach; T R W Herrmann; R Ganzer; A Blana; M Burchardt; A J Gross
Journal:  Urologe A       Date:  2009-05       Impact factor: 0.639

Review 4.  Technical aspects of lasers in urology.

Authors:  Heinrich-O Teichmann; Thomas R Herrmann; Thorsten Bach
Journal:  World J Urol       Date:  2007-05-30       Impact factor: 3.661

Review 5.  Laser treatment of benign prostatic hyperplasia.

Authors:  Rainer M Kuntz
Journal:  World J Urol       Date:  2007-05-25       Impact factor: 3.661

6.  RevoLix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up.

Authors:  Thorsten Bach; Thomas R W Herrmann; Roman Ganzer; Martin Burchardt; Andreas J Gross
Journal:  World J Urol       Date:  2007-05-25       Impact factor: 3.661

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.